This week, Fox News reported on a study which found that itching or pain on lesions could indicate skin cancer. The research was done at Temple University in Philadelphia, using 339 confirmed skin cancer lesions from 268 patients at Wake Forest University Baptist Medical Center in North Carolina.
Patients were asked to rate any pain and itching associated with their lesions. Nearly 37% of the cancerous lesions were identified with itching, and 28.2% were identified with pain. The team believes that this could change how doctors address a patient’s symptoms. They believe that asking about itching or pain could now be included in the list of questions which doctors ask about lesions.
Pain and itching were more prevalent in patients with non-melanoma skin cancers. Patients with squamous cell carcinoma (SCC) experienced more pain, while those with basal cell carcinoma (BCC) complained more about itching. According to the Skin Cancer Foundation, an estimated 700,000 cases of SCC and an estimated 2.8 million cases of BCC— the most frequently occurring form of skin cancer— are diagnosed each year in the United States.
The team believes that these symptoms may help doctors hone in on which lesions to pay most attention to. This is especially important with elderly patients who have many lesions, and transplant patients who are susceptible to skin cancer. They also noted that the lesions which are more aggressively painful or itchy may indicate a more aggressive cancer. “Itching comes from the nerve fibers in the upper layers of skin, where basal cell carcinomas are usually found. Squamous cell carcinomas can penetrate deep into the skin and form ulcers, causing more pain,” the article stated.
The article concludes that these findings should not be used in replacement for other diagnostic tests, and lesions should still be removed and studied.
We at MoleSafe agree with the team that these findings should not be used as an absolute, but there is certainly information here which is worth further studying.
What do YOU think? Let us know below!